PAULSON & CO. INC. Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001035674
What is a 13F filing? Who files one and when · What 13F filings can't tell you
John Paulson — tracked via quarterly SEC 13F filings · All famous investors
Q3 2023 · 18 positions · Total reported value $1.12B · Top-10 concentration 92.5% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 50.0% · 1 new · 2 cut · 2 exited
Active Share (vs S&P 500): 99.9% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): -8.4% · vs SPY -23.2% · Prev Value $3.11B — last quarter positions weighted by this quarter price moves · ranking
In its Q3 2023 13F filing, PAULSON & CO. INC. disclosed 18 equity positions with a combined reported value of $1.12B. The filing implies a focused portfolio: its ten largest positions account for 92.5% of reported value. HoldingsHub classifies the profile as Mid / Focused / High Turnover.
The largest disclosed positions as of Q3 2023 were HZNP ($243.30M), BHC ($217.33M), AAMI ($173.54M). By sector, the heaviest allocations are Materials 29.3%, Health Care 26.0%.
Versus the prior quarter, PAULSON & CO. INC. opened 1 new positions, trimmed 2 and fully exited 2, a turnover rate of 50.0% of positions.
The largest new positions opened in Q3 2023 were HZNP ($243.30M), BHC ($217.33M), AAMI ($173.54M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2023)
- HZNP HORIZON THERAPEUTICS PUB L · $243.30M
- BHC BAUSCH HEALTH COS INC · $217.33M
- AAMI ACADIAN ASSET MANAGEMENT INC · $173.54M
- NG NOVAGOLD RESOURCES INC COM NEW · $85.35M
- PPTA PERPETUA RES CORP COM NPV ISIN #CA7142661031 SEDOL #BNNNK40 · $80.76M
- MDGL MADRIGAL PHARMACEUTICALS INC · $73.02M
- AU ANGLOGOLD ASHANTI PLC · $60.57M
- THRY THRYV HLDGS INC · $37.54M
Fully Exited (vs previous quarter)
No tracked position was fully exited this quarter.
Insider Transactions (Form 4)
Latest John Paulson buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-08-05 | Buy | Thryv Holdings, Inc. | 144,975 | $2.79 | SEC filing |
| 2026-08-04 | Buy | Thryv Holdings, Inc. | 254,573 | $2.82 | SEC filing |
| 2026-06-17 | Sell | Acadian Asset Management Inc. | 1,900,000 | $77.25 | SEC filing |
| 2026-04-16 | Buy | INTERNATIONAL TOWER HILL MINES LTD | 4,913,665 | $2.56 | SEC filing |
Fund Profile
Paulson files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 8 positions worth $2.58B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 8 positions · $2.58B reported value (Q2 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: MDGL (MADRIGAL PHARMACEUTICALS INC) at 27.9%
- Average position size: $321.96M
Sector Tilt
- Health Care 42.0%
- Materials 40.5%
- Financials 16.2%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 1 new, 1 added, 2 reduced, 2 exited
- 4 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
2.10M | $243.30M | 21.77% | New | |
| 2 |
|
26.44M | $217.33M | 19.45% | New | |
| 3 |
|
8.95M | $173.54M | 15.53% | New | |
| 4 |
|
22.23M | $85.35M | 7.64% | New | |
| 5 |
|
24.77M | $80.76M | 7.23% | New | |
| 6 |
|
500.00K | $73.02M | 6.53% | New | |
| 7 |
|
3.83M | $60.57M | 5.42% | New | |
| 8 |
|
2.00M | $37.54M | 3.36% | New | |
| 9 |
|
783.56K | $35.61M | 3.19% | New | |
| 10 |
|
2.00M | $26.58M | 2.38% | New | |
| 11 |
|
2.07M | $21.84M | 1.95% | New | |
| 12 |
|
61.93M | $21.80M | 1.95% | New | |
| 13 |
|
2.50M | $10.57M | 0.95% | New | |
| 14 |
|
1.28M | $8.26M | 0.74% | New | |
| 15 |
|
14.33M | $7.02M | 0.63% | New | |
| 16 |
|
5.34M | $6.20M | 0.55% | New | |
| 17 |
|
50.00K | $4.34M | 0.39% | New | |
| 18 |
|
1.85M | $3.98M | 0.36% | New | |
FAQ
What did PAULSON & CO. INC. buy in 2023-Q3?
In its 2023-Q3 13F filing, PAULSON & CO. INC. reported 18 equity positions worth $1.12B in aggregate; its largest disclosed positions were HZNP ($243.30M), BHC ($217.33M), AAMI ($173.54M).
How large is PAULSON & CO. INC.'s portfolio?
PAULSON & CO. INC. reported $1.12B of long equity holdings across 18 positions as of 2023-Q3. Top-10 holdings account for 92.5% of reported value.
What is PAULSON & CO. INC.'s investment style?
HoldingsHub classifies the portfolio as Mid / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.